Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Up 225.0% in November

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 52,000 shares, a growth of 225.0% from the November 15th total of 16,000 shares. Based on an average trading volume of 273,600 shares, the short-interest ratio is presently 0.2 days.

Biodexa Pharmaceuticals Price Performance

Shares of BDRX traded down $0.16 during trading hours on Wednesday, hitting $4.52. The stock had a trading volume of 11,647 shares, compared to its average volume of 149,718. Biodexa Pharmaceuticals has a 12 month low of $3.50 and a 12 month high of $81.03. The firm has a fifty day moving average price of $5.42.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.